High Throughput Screening for Small-Molecule Inhibitors of Type III Secretion in Yersinia pestis

  • Ning Pan
  • Jon Goguen
  • Chrono Lee
Part of the Advances In Experimental Medicine And Biology book series (AEMB, volume 603)

Yersinia pestis, Yersinia pseudotuberculosis and Yersinia enterocolitica, utilize a plasmid encoded type III secretion system (T3SS) to promote infection by delivering Yersinia outer proteins (Yops) into the cytosol of mammalian cells. This T3SS is absolutely required for Yersinia virulence, which makes T3SS an attractive target in the development of novel therapeutics for treatment of plague and other Yersinia infections. In this study, a new method for high throughput screening (HTS) of small molecules for the ability to inhibit type III secretion (T3S) in Y. pestis has been developed. In comparison with screening assays employed by others, this method is very simple and rapid, and thus well suited for examining very large compound sets. Using this method, we screened a diverse collection of libraries at the US National Screening Laboratory. The initial examination of 70,966 compounds and mixtures from 13 libraries resulted in 431 primary hits. Strong positive indications of inhibition were observed at a rate of 0.01%, while moderate and weak but potentially meaningful signals were observed at rates of 0.056% and 0.54% respectively. Further characterizations were conducted on selected primary hits in Y. pestis. Of the eight compounds examined in secondary assays, four show good promise as leads for structure activity relationship studies. They are a diverse group, each having chemical scaffolds not only distinct from one another, but also distinct from previously described candidate T3S inhibitors.


High Throughput Screening Chlamydia Trachomatis Yersinia Enterocolitica Yersinia Pestis High Throughput Screen 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abe, A. (2002) Development of the screening system for the bacterial type III secretion appa-ratus inhibitor. Jpn. J. Antibiot. 55, 331-336.PubMedGoogle Scholar
  2. Ben-Gurion, R. and Shafferman, A. (1981) Essential virulence determinants of different Yersinia species are carried on a common plasmid. Plasmid 5, 183-187.CrossRefPubMedGoogle Scholar
  3. Boland, A., Sory, M.P., Iriarte, M., Kerbourch, C., Wattiau, P. and Cornelis, G.R. (1996) Status of YopM and YopN in the Yersinia Yop virulon: YopM of Y.enterocolitica is internalized inside the cytosol of PU5-1.8 macrophages by the YopB, D, N delivery apparatus. EMBO J. 15, 5191-5201.PubMedPubMedCentralGoogle Scholar
  4. Cornelis, G.R. (2002) The Yersinia Ysc-Yop ‘type III’ weaponry. Nat. Rev. Mol. Cell Biol. 3, 742-752.CrossRefPubMedGoogle Scholar
  5. Ferber, D.M. and Brubaker, R.R. (1981) Plasmids in Yersinia pestis. Infect. Immun. 31, 839-841.PubMedPubMedCentralGoogle Scholar
  6. Gauthier, A., Robertson, M.L., Lowden, M., Ibarra, J.A., Puente, J.L. and Finlay, B.B. (2005) Transcriptional inhibitor of virulence factors in enteropathogenic Escherichia coli. Antim-icrob. Agents Chemother. 49, 4101-4109.CrossRefGoogle Scholar
  7. Hakansson, S., Schesser, K., Persson, C., Galyov, E.E., Rosqvist, R., Homble, F. and Wolf-Watz, H. (1996) The YopB protein of Yersinia pseudotuberculosis is essential for the translocation of Yop effector proteins across the target cell plasma membrane and displays a contact-dependent membrane disrupting activity. EMBO J. 15, 5812-5823.PubMedPubMedCentralGoogle Scholar
  8. Higuchi, K., Kupferberg, L.L. and Smith, J.L. (1959) Studies on the nutrition and physiology of Pasteurella pestis. III. Effects of calcium ions on the growth of virulent and avirulent strains of Pasteurella pestis. J. Bacteriol. 77, 317-321.PubMedPubMedCentralGoogle Scholar
  9. Kauppi, A.M., Nordfelth, R., Uvell, H., Wolf-Watz, H. and Elofsson, M. (2003) Targeting bacterial virulence: inhibitors of type III secretion in Yersinia. Chem. Biol. 10, 241-249.CrossRefPubMedGoogle Scholar
  10. Linington, R.G., Robertson, M., Gauthier, A., Finlay, B.B., van Soest, R. and Andersen, R.J. (2002) Caminoside A, an antimicrobial glycolipid isolated from the marine sponge Caminus sphaeroconia. Org. Lett. 4, 4089-4092.CrossRefPubMedGoogle Scholar
  11. Mueller, C.A., Broz, P., Muller, S.A., Ringler, P., Erne-Brand, F., Sorg, I., Kuhn, M., Engel, A. and Cornelis, G.R. (2005) The V-antigen of Yersinia forms a distinct structure at the tip of injectisome needles. Science 310, 674-676.CrossRefPubMedGoogle Scholar
  12. Muschiol, S., Bailey, L., Gylfe, A., Sundin, C., Hultenby, K., Bergstrom, S., Elofsson, M., Wolf-Watz, H., Normark, S. and Henriques-Normark, B. (2006) A small-molecule inhibi-tor of type III secretion inhibits different stages of the infectious cycle of Chlamydia tra-chomatis. Proc. Natl. Acad.Sci. USA 103, 14566-14571.CrossRefPubMedPubMedCentralGoogle Scholar
  13. Nordfelth, R., Kauppi, A.M., Norberg, H.A., Wolf-Watz, H. and Elofsson, M. (2005) Small-molecule inhibitors specifically targeting type III secretion. Infect. Immun. 73, 3104-3114.CrossRefPubMedPubMedCentralGoogle Scholar
  14. Rosqvist, R., Forsberg, A. and Wolf-Watz, H. (1991) Intracellular targeting of the Yersinia YopE cytotoxin in mammalian cells induces actin microfilament disruption. Infect. Immun. 59, 4562-4569.PubMedPubMedCentralGoogle Scholar
  15. Rosqvist, R., Magnusson, K.E. and Wolf-Watz, H. (1994) Target cell contact triggers expres-sion and polarized transfer of Yersinia YopE cytotoxin into mammalian cells. EMBO J. 13, 964-972.PubMedPubMedCentralGoogle Scholar
  16. Wolf, K., Betts, H.J., Chellas-Gery, B., Hower, S., Linton, C.N. and Fields, K.A. (2006) Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle. Mol. Microbiol. 61, 1543-1555.CrossRefPubMedPubMedCentralGoogle Scholar
  17. Zhang, J.H., Chung, T.D. and Oldenburg, K.R. (1999) A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen 4, 67-73.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Ning Pan
    • 1
  • Jon Goguen
    • 1
  • Chrono Lee
    • 1
  1. 1.Department of Molecular Genetics and MicrobiologyUniversity of Massachusetts Medical SchoolWorcesterUSA

Personalised recommendations